You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stem cell transplantation, non-myeloablative

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Stem cell infusion
  • +5 more
  • Saint Louis, Missouri
    Washington University
Jan 17, 2023

Predict T Cell Chimerism After MSD SCT for SCD?

Recruiting
  • Sickle Cell Disease
  • Alemtuzumab Injection [Campath]
  • Amsterdam, Netherlands
    Amsterdam Medical Centre
Jun 20, 2023

Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)

Active, not recruiting
  • Refractory Non Hodgkin Lymphoma
  • Relapsed Non Hodgkin Lymphoma
  • rituximab
  • +7 more
  • Sacramento, California
    University of California Davis
Nov 28, 2022

Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, L1, Leukemia, Lymphoblastic, Acute, L2 Trial in Melbourne (Venetoclax,

Recruiting
  • Leukemia, Myeloid, Acute
  • +5 more
  • Melbourne, Victoria, Australia
    Melbourne Health
Jun 19, 2022

B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from

Recruiting
  • B-Cell Lymphoid Malignancies
  • +2 more
  • Hematopoietic Stem Cells from HLA-compatible Related
  • Hematopoietic Stem Cells from HLA Unrelated
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
May 5, 2022

Stem Cell Transplantation, Rehabilitation Trial in Aarhus (Multimodal interdisciplinary rehabilitation programme (HAPPY))

Completed
  • Stem Cell Transplantation
  • Rehabilitation
  • Multimodal interdisciplinary rehabilitation programme (HAPPY)
  • Aarhus, Denmark
    Dep. of Hem. Aarhus Universitetshospital
Nov 2, 2021

Sickle Cell Disease Trial in Chicago (Allogeneic Non-Myeloablative Stem Cell Transplantation, Alemtuzumab, Sirolimus)

Recruiting
  • Sickle Cell Disease
  • Allogeneic Non-Myeloablative Stem Cell Transplantation
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
Feb 16, 2022

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

Recruiting
  • Acute Leukemia
  • +27 more
  • HSCT with TBI Regimen
  • HSCT with Non-TBI Regimen
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Apr 12, 2022

B-Cell Non-Hodgkin Lymphoma, DLBCL, Mantle Cell Lymphoma Trial in Duarte (Anti-CD19-CAR CMV-specific T-lymphocytes, Autologous

Not yet recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Anti-CD19-CAR CMV-specific T-lymphocytes
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jun 28, 2022

Sickle Cell Disease Trial in Amsterdam (Engerix-B)

Recruiting
  • Sickle Cell Disease
  • Amsterdam, Netherlands
    Amsterdam Medical Centre
Jan 6, 2022

Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

Not yet recruiting
  • Recurrent Severe Aplastic Anemia
  • Refractory Severe Aplastic Anemia
  • Anti-Thymocyte Globulin
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 23, 2023

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +29 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 4, 2023

Tumor Metastasis Trial run by the NHLBI (methotrexate, Cyclosporin)

Terminated
Has Results
  • Neoplasm Metastasis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 8, 2021

Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

Active, not recruiting
  • Acute Leukemia
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Myelodysplastic Syndrome RAEB-I or RAEB-II, Refractory Acute Myeloid Leukemia, Refractory CML Myeloid Blast Crisis Trial in

Completed
  • Myelodysplastic Syndrome RAEB-I or RAEB-II
  • +2 more
  • GM-CSF secreting leukemia vaccine
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 28, 2022

B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma Trial in Valhalla (Polatuzumab vedotin)

Recruiting
  • B-cell Lymphoma
  • +8 more
  • Polatuzumab vedotin
  • Valhalla, New York
    New York Medical Center
Oct 29, 2021

Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Non-myeloablative haploidentical

Not yet recruiting
  • Sickle Cell Disease
  • Non-myeloablative haploidentical peripheral blood stem celltransplantation with briquilimab and abatacept
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023

Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Stanford (biological, drug,

Completed
Has Results
  • Acute Myeloid Leukemia
  • +6 more
  • Anti-Thymocyte Globulin
  • +5 more
  • Stanford, California
    Stanford University, School of Medicine
Jun 1, 2021

Multiple Myeloma Trial in Worldwide (HLA Matched allogeneic transplant)

Completed
  • Multiple Myeloma
  • HLA Matched allogeneic transplant
  • Wien, Austria
  • +23 more
Oct 5, 2021

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Reduced-Intensity Conditioning Regimen
  • Myeloablative Conditioning Regimen
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Jan 4, 2023

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia Trial in United Kingdom (Reduced intensity haplodentical

Active, not recruiting
  • Hodgkin's Lymphoma
  • +8 more
  • Reduced intensity haplodentical stem cell transplant
  • Myeloablative haploidentical stem cell transplant
  • Birmingham, United Kingdom
  • +11 more
Sep 27, 2021

Stiff-Person Syndrome Trial in Chicago (Autologous Hematopoietic Stem Cells, Cyclophosphamide, Mesna)

Terminated
Has Results
  • Stiff-Person Syndrome
  • Autologous Hematopoietic Stem Cells
  • +6 more
  • Chicago, Illinois
    Northwestern University
Jan 6, 2021

Hematologic Malignancies Trial in Lebanon (Stem Cell Transplant, G-CSF, Fludarabine)

Completed
Has Results
  • Hematologic Malignancies
  • Stem Cell Transplant
  • +5 more
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Oct 30, 2020

Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Fludarabine + Total Marrow Irradiation
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Jun 1, 2022

Sickle Cell Disease Trial in Chicago (aß+ T-cell depletion with Miltenyi CliniMACS system)

Recruiting
  • Sickle Cell Disease
  • αβ+ T-cell depletion with Miltenyi CliniMACS system
  • Chicago, Illinois
    The University of Chicago
May 13, 2022